VILDAGLIPTIN

作品数:18被引量:54H指数:4
导出分析报告
相关领域:医药卫生更多>>
相关作者:叶香丽更多>>
相关机构:东华大学重庆医科大学更多>>
相关期刊:《Computer Modeling in Engineering & Sciences》《World Journal of Diabetes》《World Journal of Meta-Analysis》《国外药讯》更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
Efficacy of Bee Products(Anzer Honey,Pollen and Propolis)in Detection and Healing of Damage Induced by Antidiabetic Drug Vildagliptin/Metformin Hydrochloride in Healthy Human Pancreatic Cells:Cytotoxic,Genotoxic and Biochemical Studies
《Current Medical Science》2023年第6期1173-1182,共10页ÖzlemÖzdemir ZinetÇöl Ömer Ertürk 
Ordu University Scientific Project Coordination Department(ODUBAP,No.B-2139).
Background and Objective Although drugs are powerful therapeutic agents,they have a range of side effects.These side effects are sometimes cellular and not clinically noticeable.Vildagliptin/metformin hydrochloride is...
关键词:cell viability hTERT-HPNE Anzer bee products drug side effect diabetes mellitus 
Short-Term Effects of Liraglutide versus Vildagliptin on Insulin Secretion and Sensitivity in Type 2 Diabetes: A Single Blinded Randomized Controlled Trial (LIRAVIS Study)被引量:1
《Journal of Diabetes Mellitus》2023年第1期45-57,共13页Martine Claude Etoa Etoga Estelle Amandine Well Simeon Pierre Choukem Mesmin Dehayem Francine Mendane Mekobe Anne Boli Ongmeb Astasselbe Hadja Inna Jean Claude Mbanya Eugene Sobngwi 
Background: We aimed to evaluate the short-term metabolic effects of a GLP-1a, (liraglutide) versus a DPP-4i, (vildagliptin) in a group of sub-Saharan type 2 diabetes patients. Methods: We conducted a randomized contr...
关键词:Insulin Sensitivity Insulin Secretion LIRAGLUTIDE VILDAGLIPTIN Incretinomimetics 
Anti-cancer effects of sitagliptin,vildagliptin,and exendin-4 on triple-negative breast cancer cells via mitochondrial modulation
《BIOCELL》2022年第12期2645-2657,共13页POOJA JAISWAL VERSHA TRIPATHI ANSHUL ASSAIYA DHARMENDRA KASHYAP RAHUL DUBEY ANAMIKA SINGH JANESH KUMAR HEM CHANDRA JHA RAJESH SHARMA AMIT KUMAR DIXIT HAMENDRA SINGH PARMAR 
The work was supported by the Council of Scientific and Industrial Research-Junior Research Fellowship to Ms.Pooja Jaiswal(File No.09/301(0137)/2019-EMR-I);Ms.Versha Tripathi(09/301(0138)/2019-EMR-I);We also acknowledge the India-Belarus joint project(DST/INT/BLR/P-24/2019)funded by the Department of Science and Technology;New Delhi and the research grant from Devi Ahilya University,Indore(Dev/Seedmoney2.0/2020-21/655)sanctioned to Dr.Hamendra Singh Parmar.
Triple-negative breast cancer(TNBC)cell line MDA-MB-231 is known for Warburg metabolism and defects in mitochondria.On the other hand,dipeptidyl peptidase-IV(DPP-IV)inhibitors such as sitagliptin and vildagliptin and ...
关键词:SITAGLIPTIN VILDAGLIPTIN EXENDIN-4 Apoptosis Migration VIABILITY Chemo-sensitivity Mitochondrial biogenesis 
Validated Chiral Ultra Fast Liquid Chromatographic Method for Quantitative Analysis of Enantiomeric Vildagliptin
《American Journal of Analytical Chemistry》2021年第11期429-439,共11页Chinta Srinivas Husna Kanwal Qureshi Ciddi Veeresham 
A rapid, accurate, and precise chiral Ultra fast liquid chromatography (UFLC) method was developed and validated for enantiomeric separation of racemic vildagliptin and S-vildagliptin according to the guideline...
关键词:Standard Vildagliptin S-Vilda Ultra Fast Liquid Chromatography Method Development Validation 
Drug interactions of dipeptidyl peptidase 4 inhibitors involving CYP enzymes and P-gp efflux pump
《World Journal of Meta-Analysis》2019年第4期156-161,共6页Naina Mohamed Pakkir Maideen 
Dipeptidyl peptidase 4(DPP4) inhibitors are oral antidiabetic drugs approved to manage type 2 diabetes mellitus. Saxagliptin is a substrate of CYP3A4/5 enzymes while other DPP4 inhibitors such as sitagliptin, linaglip...
关键词:Drug interactions SITAGLIPTIN SAXAGLIPTIN LINAGLIPTIN Gemigliptin Teneligliptin VILDAGLIPTIN Anagliptin CYP3A4 P-GP EFFLUX pump 
Mechanism Based Pharmacokinetic Pharmacodynamic Modeling of Vildagliptin as an Add-on to Metformin for Subjects with Type 2 Diabetes
《Computer Modeling in Engineering & Sciences》2018年第2期153-171,共19页Marziyeh Eftekhari Omid Vahidi 
Various drugs are used to maintain normoglycemia in subjects with type 2 diabetes mellitus.The combination of the drugs from different classes in one single tablet may enhance the effectiveness of the anti-diabetic dr...
关键词:Pharmacokinetics PHARMACODYNAMICS mathematical modeling ANTI-DIABETIC drugs METFORMIN VILDAGLIPTIN 
Clinical and Biochemical Changes in Polycystic Ovarian Syndrome Patients in Response to 3 Different Oral Hypoglycemic Drugs: A Double Blind Randomized Controlled Study
《Open Journal of Obstetrics and Gynecology》2017年第1期117-128,共12页Ahmed S. El-Halwagy Adel A. Al-Gergawy Engy S. Eleslam Enaam S. Abd Elbar 
Introduction: This study was done to evaluate other oral hypoglycemic medications;especially the new ones in the management of PCOS patients as alternatives to the standard medication used for this purpose Metformin. ...
关键词:PCOS Pioglitazobe VILDAGLIPTIN METFORMIN 
Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan
《World Journal of Diabetes》2013年第6期358-364,共7页Abhijit Shete Aheson Shaikh K Javeed Nayeem Lily Rodrigues Mohamed Sheikamunadeen Sadiq Ali Parag Shah Rajiv Khanna Sarfaraj Majid Sabeer A Rasheed Shehla Shaikh Tawfiqur Rahman 
Supported by Novartis Healthcare Private Limited,India
AIM:To compare the use of vildagliptin and sulfonylurea with or without metformin in Indian Muslim patients with type 2 diabetes mellitus,fasting during Ramadan.METHODS:This was a 4-wk,multicenter,non-interventional,o...
关键词:Dipeptidyl-peptidase 4 inhibitors FASTING hypoglycemia SULFONYLUREA Type 2 DIABETES mellitus VILDAGLIPTIN 
Dipeptidyl peptidase-4: A key player in chronic liver disease被引量:25
《World Journal of Gastroenterology》2013年第15期2298-2306,共9页Minoru Itou Takumi Kawaguchi Eitaro Taniguchi Michio Sata 
Dipeptidyl peptidase-4 (DPP-4) is a membrane-associated peptidase, also known as CD26. DPP-4 has widespread organ distribution throughout the body and exerts pleiotropic effects via its peptidase activity. A represent...
关键词:INCRETIN Viral hepatitis Insulin resistance STEATOHEPATITIS Cancer SITAGLIPTIN VILDAGLIPTIN ALOGLIPTIN Teneligliptin LINAGLIPTIN 
Vildagliptin-insulin combination improves glycemic control in Asians with type 2 diabetes被引量:6
《World Journal of Diabetes》2013年第4期151-156,共6页Plamen Kozlovski James Foley Qing Shao Valentina Lukashevich Wolfgang Kothny 
Supported by Novartis Pharma AG
AIM: To assess the efficacy and safety of vildagliptin 50 mg bid as add-on therapy to insulin in Asian patients with type 2 diabetes mellitus(T2DM).METHODS: This was a post hoc analysis of a subgroup of Asian patients...
关键词:ASIAN DPP-4 inhibitor HYPOGLYCEMIA INSULIN Oral ANTIDIABETIC drug Type 2 diabetes VILDAGLIPTIN 
检索报告 对象比较 聚类工具 使用帮助 返回顶部